资源描述
|RDN 2019 4000 RDN RDN 2030 105 RDN RDN 2008 2009 SymplicityTMHTN-1 HTN-2 2014 HTN-3 RDN 2020 SPYRAL HTN OFF-MED RDN ReCor Medical RDN 2022 11 FDA RDN RDN ReCor Covidien SyMap Renaly RDN RDN FDA RDN RDN RDN RDN RDN RDN-U(688351)-B(02185)-B(02500)-B(06922)RDN/2023 04 19 01066218100*828 S0860519040001 BSW684 S0860522100002 AACR 2023-04-08 2023-03-22 2023-02-12 2 RDN.4 1.1.4 1.2.6 RDN.8 2.1 RDN 2014 2020.8 2.2.11 2.2.1 RDN 11 2.2.2 FDA 13 2.3 RDN.15 RDN.16.19.19 0YDWwPqNtQqRrPmPsPtMoP6MaO8OmOoOoMtQlOoOnRfQnPmM8OqQzRNZtPmRMYnRoR 3 1 2015-2030.4 2.5 3 HTN.5 4 HTN 1.6 5.6 6.7 7.7 8.7 9 59 7 RDN.8 10 SymplicityTM HTN-3.9 11.10 12 SPYRAL HTN OFF-MED RDN 24.10 13 Spyral HTN-ON MED.12 14 RDN.12 15 RADIANCE 2.12 16 RDN.13 17 Symplicity.13 18 RDN.14 19 RDN.14 20.16 21.17 22 Iberis.18 23 Iberis.18 1 2023.15 2 4.16 4 RDN HTN 2019 4000 RDN RDN RDN 1.1(SBP)140 mmHg()(DBP)90 mmHg 2018 27.5%3 1./140 90 2.RH 140/90 3.UH 2019 15%RH 63%UH 22%2.3%2015 2.90 2019 3.17 2019 2030 1.8%3.88 2.12 5820 1 2015-2030 5 2(2018)20%60%80%4783 IV HTN 3 HTN 050100150200250300350400450()UH RH 6 NHANES 4 HTN 1 NHANES 1.2 Renal Denervation RDN 1950 Smithwick RDN-RAAS-5 7 Recor Medical RDN-RAAS RDN 6 7 2009 30 8 8 Recor Medical RDN RDN 1 2 3 RDN Recor Medical 2030 105 RDN 2.1 RDN 2014 2020 RDN RDN 2008 2009 SymplicityTMHTN-1 HTN-2 2012-2013 7 CE/ReCor Medical Covidien 9 59 7 RDN 9 2014 SymplicityTM HTN-3 RDN RDN RDN SymplicityTM HTN-3 RDN RDN 10 SymplicityTM HTN-3 Sakakura et al,JACC2014 HTN-3 SymplicityTM HTN-3 RND 10 HTN-3 RDN 11 Sakakura et al,JACC2014 HTN-3 2015 SPYRAL HTN-OFF MED 2020 3 RDN SPYRAL HTN OFF-MED RDN ESC2017 3 RDN 24 24 SBP 5.5 mm Hg 95 CI-9.1-2.0 P=0.0031 24 DBP 4.8 mm Hg 95 CI-7.0-2.6 P 0.0001 SBP 10.0 mm Hg 95 CI-15.1-4.9 P=0.0004 DBP 5.3 mm Hg 95 CI-7.8-2.7 P=0.0002 RDN 12 SPYRAL HTN OFF-MED RDN 24 ESC 11 RDN RDN SIMPLICITY HTN-3 SPYRAL HTN OFF-MED 1 SPYRAL 2 38mm 3 RDN 4 2.2 2.2.1 RDN SPYRAL HTN-OFF MED RDN 2020 Symplicity Spyral ReCor Medical Paradise SoniVie FDA 2022 EuroPCR RDN RDN SPYRAL HTN-ON MED Global Symplicity Registry GSR ReCor RADIANCE-HTN SOLO RDN Spyral HTN-ON MED Expansion Symplicity Spyral RDN OFF MED ON MED RDN ACE/ARB SBP 6 RDN n=199 SBP 9.9mmHg n=126 4.9mmHg-4.9 mmHg p=0.001 RDN 24 ABPM SBP 6.5mmHg 4.5mmHg-1.9 mmHg p=0.119 24 ABPM Win Ratio RDN 24 RDN 1.5(p=0.005)6 RDN 12 p=0.04 Win Ratio Win Ratio RDN 13 Spyral HTN-ON MED 14 RDN Clinic Clinic RADIANCE-HTN SOLO RDN 4 135/85 mmHg RDN 74 72 RDN 12 16.5 12.9 mmHg RDN 2 6 RADIANCE Pooled RDN 15 RADIANCE 2 GSR SPYRAL major adverse cardiovascular event MACE 3077 3 12 TTR Time in Therapeutic Range 13 10%24 MACE RDN 2.2.2 FDA 2022 5 17 SPYRAL HTN-ON MED GSR-DEFINE 2022 11 FDA RDN Symplicity Symplicity Spyral FDA HTN-3 GSR Spyral HTN-OFF MED Spyral HTN-ON MED RDN 16 RDN Clinic Always-on GSR Spyral HTN-ON MED Pilot RDN 3-10mmHg 24 0-6 TTR 10%6-36 MACE 16%17 Symplicity 14 18 RDN RDN FDA RDN 2009 SYMPLICITY HTN-1 HTN-2 HTN-3 SPYRAL HTN-OFF MED ON MED GSR GSR RDN 3000 RDN RDN 19 RDN 15 2.3 RDN RDN RDN 2023/RDN RDN RDN RDN 1 2023 RDN 2023/3/11 RDN RDN RDN RDN 2023/2/15 RDN RDN 24 RDN RDN 3 5-10 mmHg RDN 3 eGFR 40 ml/min1.73 m2 140/90 mmHg 24 130 mmHg 135 mmHg 2023/1/1 RDN RDN 16 ABP 24 sABP 130 mmHg/dABP 80 mmHg OBP sOBP 140 mmHg/dOBP 90 mmHg 2022 10 Symplicity GSR-Symplicity SpyralTM RDN RDN 20 RDN 2022 HTN-3 ReCor Covidien SyMap Renaly 2020 4 FDA 4 SoniVie Recor Medical 2 4 RDN FDA CE NMPA Symplicity Spyral 4 6F 3-8mm 2020 3 2022 11 7 2013 2017 2021 4 17 FDA Netrod 6 8F 3-12mm 2021 9 FDA IDE 2020 7 2019 2022 3 NMPA Paradise ReCor Medical 7F/2018 FDA IDE 2020 12 2012/TIVUS SoniVie/2020 12 2022 FDA IDE 2014/2022 5 17 SPYRAL HTN-ON MED FDA RDN RDN 2020 RDN CE 2021 9 FDA 2021 RDN 2022 11/Iberis RDN 2023 4 11 RDN 2022 12 FDA Renaly 3 RDN FDA 21 TRI TFI 18 HTN-3 6 22 Iberis 23 Iberis RDN 1 RDN 2 RDN RDN RDN 3 70%4 19 5 RDN 10-20 RDN RDN RDN Recor FDA RDN RDN RDN-U(688351)-B(02185)-B(02500)-B(06922)RDN RDN RDN RDN RDN 20 Tabl e_Disclai mer 12/15%5%15%-5%+5%-5%5%-5%+5%-5%HeadertTabl e_Discl ai mer HeadertTabl e_Address 318 26 021-63325888 021-63326786 Tabl e_Disclai mer 前沿报告库是中国新经济产业咨询报告共享平台。行业范围涵盖新一代信息技术、5G、物联网、新能源、新材料、新消费、大健康、大数据、智能制造等新兴领域。为企事业单位、科研院所、投融资机构等提供研究和决策参考。扫一扫免费获取海量报告
展开阅读全文